You have 9 free searches left this month | for more free features.

predictive biomarker

Showing 26 - 50 of 8,599

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Hepatocellular Carcinoma Treated With Systemic Therapy

Recruiting
  • Hepatocellular Carcinoma
  • atezolizumab plus bevacizumab
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Jan 5, 2022

Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in Houston (Nivolumab)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Solid Neoplasm
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 1, 2021

Alzheimer's Disease, Mild Cognitive Impairment Trial in Paris (biomarkers, MRI and CSF)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • biomarkers, MRI and CSF
  • Paris, France
    APHP, Hôpital Broca
Nov 19, 2021

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Plasma Biomarkers P-DAC, V1

Terminated
  • Pancreatic Ductal Adenocarcinoma
    • Bracken Rd, Sandyford Industrial Estate, Dublin 18, Ireland
    • +8 more
    Jan 14, 2022

    Predicting Biomarker of Gastric Cancer Chemotherapy Response

    Recruiting
    • Gastric Cancer
    • +2 more
    • Daegu, Korea, Republic of
      Kyungpook National University Medical Canter
    Aug 8, 2021

    Colorectal Cancer Liver Metastases Trial in New York ([18-F]- FDG - PET, Thermal ablation (TA), PET/CT Scan)

    Recruiting
    • Colorectal Cancer Liver Metastases
    • [18-F]- FDG - PET
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 16, 2022

    A Multi Biomarker Approach In Metastatic GEP NETs

    Completed
    • Gastroenteropancreatic Neuroendocrine Tumors
    • This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.
    • Aarhus, Denmark
    • +24 more
    Dec 6, 2021

    Exosomal and Free Extracellular RNAs and Proteins as Predictive

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Biomarker Analysis
    • Cork, Ireland
    • +10 more
    Oct 8, 2021

    C-myc Biomarker Study for Diabetic Foot Ulcers

    Recruiting
    • Diabetes
    • +3 more
      • San Francisco, California
      • +5 more
      Mar 9, 2022

      Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy

      Completed
      • Preeclampsia
        • Odense, Denmark
          Odense University Hospital
        Oct 16, 2020

        Identify a Predictive Biomarker for Immunotherapy

        Unknown status
        • Lung Cancer
          • Seoul, Gangnam-gu, Korea, Republic of
          • +2 more
          Mar 23, 2020

          Peripheral Blood for Nivolumab Therapy in NSCLC Patients

          Completed
          • Non -Small Cell Lung Cancer
          • nivolumab
          • Seoul, Korea, Korea, Republic of
            Department of Oncology, Yonsei University College of Medicine
          Oct 14, 2020

          Dermatitis, Atopic Trial in Rotterdam (Topical corticosteroids, Systemic cyclosporine, Systemic dupilumab)

          Recruiting
          • Dermatitis, Atopic
          • Topical corticosteroids
          • +2 more
          • Rotterdam, Zuid-Holland, Netherlands
            Erasmus MC - Sophia Children's Hospital
          Aug 17, 2021

          Evaluation of Volatile Organic Compounds in Mepolizumab Therapy

          Not yet recruiting
          • Asthma; Eosinophilic
          • Mepolizumab
          • Southampton, United Kingdom
            University Hospital Southampton NHS Foundation Trust
          Jun 10, 2021

          Prostate Cancer Trial in San Francisco (Pyruvate (13C), MRI)

          Terminated
          • Prostate Cancer
          • Pyruvate (13C)
          • MRI
          • San Francisco, California
            University of California, San Francisco
          Jul 22, 2020

          End-stage Renal Disease Trial (Blood samples)

          Not yet recruiting
          • End-stage Renal Disease
          • Blood samples
          • (no location specified)
          Jan 28, 2020

          Metastatic Ovarian Cancer Trial in Bordeaux, Montpellier (Experimental arm)

          Completed
          • Metastatic Ovarian Cancer
          • Experimental arm
          • Bordeaux, France
          • +1 more
          Oct 16, 2020

          Early-Stage Non-Small Cell Lung Cancer Previously Treated With

          Completed
          • Lung Cancer
          • Laboratory Biomarker Analysis
          • Syracuse, New York
            SUNY Upstate Medical University
          Jan 19, 2021

          Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC

          Unknown status
          • Non Small Cell Lung Cancer
          • Sample collection
          • (no location specified)
          Mar 13, 2020

          Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

          Active, not recruiting
          • Non Small Cell Lung Cancer
          • Immune signature in serum associated to the metabolic signature
          • Meta-genomic signature of intestinal flora
          • La Tronche, Isère, France
            University Hospital, Grenoble
          Jan 6, 2023

          Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

          Not yet recruiting
          • Hepatocellular Carcinoma
          • +4 more
          • Liquid Biopsy
          • (no location specified)
          Apr 18, 2023

          Hypertension, Pulmonary Trial in Worldwide (Blood Sample)

          Completed
          • Hypertension, Pulmonary
          • Blood Sample
          • Los Angeles, California
          • +48 more
          Apr 26, 2022

          Sarcoma Trial in Shanghai (Apatinib monotherapy)

          Recruiting
          • Sarcoma
          • Apatinib monotherapy
          • Shanghai, Shanghai, China
            Ruijin Hospital Shanghai Jiao Tong University School of Medicine
          May 18, 2022

          Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Carcinoma Trial in Tampa, Houston (radiation, other, biological)

          Completed
          • Multiple Endocrine Neoplasia Type 1
          • Pancreatic Neuroendocrine Carcinoma
          • Computed Tomography Perfusion Imaging
          • +2 more
          • Tampa, Florida
          • +2 more
          Mar 18, 2020